COTRIM Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cotrim, and what generic alternatives are available?
Cotrim is a drug marketed by Teva and is included in two NDAs.
The generic ingredient in COTRIM is sulfamethoxazole; trimethoprim. There are twenty-seven drug master file entries for this compound. Forty-nine suppliers are listed for this compound. Additional details are available on the sulfamethoxazole; trimethoprim profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cotrim
A generic version of COTRIM was approved as sulfamethoxazole; trimethoprim by SUN PHARM INDUSTRIES on August 25th, 1986.
Summary for COTRIM
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 24 |
Clinical Trials: | 3 |
Formulation / Manufacturing: | see details |
DailyMed Link: | COTRIM at DailyMed |
Recent Clinical Trials for COTRIM
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Roswell Park Cancer Institute | Phase 4 |
National Cancer Institute (NCI) | Phase 4 |
Harvard School of Public Health (HSPH) | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for COTRIM
US Patents and Regulatory Information for COTRIM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Teva | COTRIM | sulfamethoxazole; trimethoprim | TABLET;ORAL | 070034-001 | May 16, 1985 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Teva | COTRIM D.S. | sulfamethoxazole; trimethoprim | TABLET;ORAL | 070048-001 | Mar 18, 1985 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |